Day: April 29, 2020

ROLLING MEADOWS, Ill., April 29, 2020 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and western Canada, announced today its first-quarter 2020 financial results.HighlightsFirst quarter revenues of $518.5 millionFirst-quarter net income attributable to MYR of $9.9 million, or $0.59 per diluted shareFirst-quarter EBITDA of $27.4 millionRecord backlog of $1.54 billionManagement CommentsRick Swartz, MYR’s President and CEO, said, “Our first-quarter 2020 financial results included $518.5 million of revenues, a 10.8 percent increase over the first quarter of 2019, and increases in gross profit, earnings per share, net income and EBITDA. Backlog in the first quarter...

Full Enrollment of Two Phase 3 Trials in Geographic Atrophy Expected in the Second Quarter of 2020Meetings with US and EU Regulators to Discuss Submissions in Paroxysmal Nocturnal Hemoglobinuria (PNH) Planned for the Second Quarter of 2020Completion of Enrollment in Phase 3 PRINCE Trial in Treatment-Naïve PNH Patients also Expected in Second Quarter of 2020Cash and Investments of $648 Million as of March 31, 2020WALTHAM, Mass., April 29, 2020 (GLOBE NEWSWIRE) —  Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced its first quarter 2020 financial results and business highlights.“This past quarter, the COVID-19 pandemic presented the biotechnology industry – and the world – with many serious challenges. At Apellis, we have been fortunate on several fronts....

First Quarter 2020 HighlightsQ1 revenue of $154.2 million, up 6.0% year-over-yearQ1 Subscription-based platform revenue of $137.1 million, up 13.1% year-over-year, equating to 89% of Q1 total revenueQ1 net loss of $1.7 million, resulting in diluted net loss of $0.01 per shareQ1 Non-GAAP net income of $16.2 million, up 10% year-over-year, resulting in Non-GAAP net income of $0.11 per shareQ1 Adjusted EBITDA of $47.5 million, up 7% year-over-year, resulting in Adjusted EBITDA margin of 30.8%Q1 net cash provided by operating activities of $14.1 millionQ1 new sales Annual Contract Value (ACV)1 totaled $45.5 millionDebt & Cash HighlightsExecuted repricing of credit facility on February 11, 2020, decreasing applicable interest rateExecuted proactive opportunistic draw down on revolver for $99 million on March 13, 2020Cash balance as of...

Converse, IN, April 29, 2020 (GLOBE NEWSWIRE) — In the brief period since the federal passage of the CARES Act, First Farmers Bank & Trust has joined forces with banks around the country to assist business owners to secure emergency financing through the Payroll Protection Program (PPP). Through two periods of applications, FFBT employees have increased work schedules and expedited the traditional application and underwriting process to help commercial clients navigate this program.  Since April 3rd, over 1000 FFBT business clients have obtained low interest loans to help assist the needs of furloughed employees and maintain the stability of the small business economy. All loans are 100% guaranteed by the Small Business Administration (SBA). If businesses utilize at least 75% of the proceeds for payroll expense, a large portion...

OVERLAND PARK, Kan., April 29, 2020 (GLOBE NEWSWIRE) — YRC Worldwide Inc. (NASDAQ: YRCW), announced today that on Tuesday May 5, 2020, at 5:00 p.m. ET, company executives will host a conference call with the investment community to discuss first quarter 2020 results. The financial results will be released the same day, May 5, 2020, after the market closes.The call will be webcast and can be accessed live or as a replay via the YRC Worldwide website yrcw.com.About YRC WorldwideYRC Worldwide Inc., headquartered in Overland Park, Kan., is the holding company for a portfolio of less-than-truckload (LTL) companies including Holland, New Penn, Reddaway, and YRC Freight, as well as the logistics company HNRY Logistics. Collectively, YRC Worldwide companies have one of the largest, most comprehensive logistics and LTL networks in North...

SUNNY ISLES BEACH, Fla., April 29, 2020 (GLOBE NEWSWIRE) — Icahn Enterprises L.P. (NASDAQ:IEP) announced today that it will discuss its first quarter 2020 results on a conference call and webcast on Friday, May 8, 2020 – 10:00 a.m. Eastern Time. The webcast can be viewed live on Icahn Enterprises L.P.’s website at www.ielp.com. It will be archived and made available at www.ielp.com under the Investor Relations section. The toll-free dial-in number for the conference call in the United States is (866) 393-0676. The international number is (253) 237-1149. The passcode to access the conference call is 6985725.Icahn Enterprises L.P., a master limited partnership, is a diversified holding company engaged in seven primary business segments: Investment, Energy, Automotive, Food Packaging, Metals, Real Estate and Home Fashion.Caution...

LIVERMORE, Calif., April 29, 2020 (GLOBE NEWSWIRE) — McGrath RentCorp (NASDAQ: MGRC) (the “Company”), a diversified business-to-business rental company, today announced total revenues for the quarter ended March 31, 2020 of $129.5 million, an increase of 6%, compared to the first quarter of 2019.  The Company reported net income of $20.2 million, or $0.81 per diluted share, for the first quarter of 2020, compared to net income of $18.4 million, or $0.75 per diluted share, for the first quarter of 2019. FIRST QUARTER 2020 COMPANY HIGHLIGHTS:Income from operations increased 9% year-over-year to $29.7 million.Rental revenues increased 8% year-over-year to $89.5 million.Adjusted EBITDA1 increased 10% year-over-year to $54.9 million.   Dividend rate increased 12% year-over-year to $0.42 per share for the first quarter of 2020.  On an...

Revenue: $611 million, up 22% from the first quarter of 2019EBITDA Margin: 9.0%Diluted EPS: $0.71, up 34% from the first quarter of 2019Adjusted Diluted EPS: $0.81, up 31% from the first quarter of 2019Bookings of $1.1 billion resulting in a book-to-bill ratio of 1.8Cash Flow from Operations: $43 millionHERNDON, Va., April 29, 2020 (GLOBE NEWSWIRE) — ManTech International Corporation (Nasdaq:MANT), a leading provider of innovative technologies and solutions for mission-critical national security programs, today announced financial results for the first quarter of fiscal year 2020, which ended March 31, 2020.“ManTech’s steadfast prioritization of its customers and employees continues to yield long-term shareholder value creation. In the quarter, we delivered healthy organic growth, won new work at scale, improved profitability...

SILICON SLOPES, Utah, April 29, 2020 (GLOBE NEWSWIRE) — Pluralsight, Inc. (NASDAQ: PS), the enterprise technology skills company, today announced financial results for the first quarter ended March 31, 2020.“We went into the year with overall strength in the business prior to hitting the pandemic headwinds.  We have moved aggressively with our cost structure to preserve balance sheet flexibility while investing in our product, which the world needs now more than ever,” said Aaron Skonnard, co-founder and CEO of Pluralsight. “During this time of uncertainty, we believe companies that invest in technology skills development give themselves the chance to rebound stronger as we emerge from this pandemic.  As a result of focusing on our customer’s immediate needs and partnering to problem solve, we expect that in the long term all of...

Rockville, MD, April 29, 2020 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced three clinical presentations at the American Society of Clinical Oncology (ASCO) upcoming ASCO20 Virtual Scientific Program to be held May 29-31, 2020.ASCO Virtual PresentationsTitle: A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD-1 and LAG-3, in patients with unresectable or metastatic neoplasmsAuthors: Jason J. Luke, et al.Session: Developmental Therapeutics—ImmunotherapySession Type: Oral Abstract SessionAbstract: 3004Title: Preliminary dose escalation results from a phase I/II, first-in-human study of MGC018 (anti-B7-H3...